All Stories

  1. Clozapine may consistently protect from suicidal behaviors while other antipsychotics may lack a specific protective effect: a comprehensive VigiBase study interpreted in the context of the prior literature
  2. Exploring the Relationship Between Psychological Constructs and Decision-Making Preferences in Psychiatric Outpatients
  3. Implications of psychological reactance for clinical practice in psychiatry including a systematic review.
  4. Investigating in VigiBase® over 6000 cases of pneumonia in clozapine-treated patients in the context of the literature: focus on high lethality and the association with aspiration pneumonia
  5. Psychoeducational group interventions for adults diagnosed with attention-deficit/ hyperactivity disorder: a scoping review of feasibility, acceptability, and outcome measures
  6. Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK
  7. Clozapine-associated pericarditis and pancreatitis in children and adolescents: A systematic literature review and pharmacovigilance study using the VigiBase database
  8. An expert review of clozapine in Latin American countries: Use, monitoring, and pharmacovigilance
  9. Will ChatGPT3 Substitute for us as Clozapine Experts?
  10. Guía internacional Para una dosificación más Segura de la clozapina en adultos mediante el uso de 6 titulaciones personalizadas de dosis basados en la etnicidad, la Proteína C Reactiva y los niveles de clozapina
  11. An expert review of clozapine in Eastern European countries: Use, regulations and pharmacovigilance
  12. Psychiatric Patients’ Perceived Health Control and Reactance: Implications for Medication Adherence
  13. Exploring low clozapine C/D ratios, inverted clozapine-norclozapine ratios and undetectable concentrations as measures of non-adherence in clozapine patients
  14. Adverse drug reactions and their fatal outcomes in clozapine patients in VigiBase: Comparing the top four reporting countries (US, UK, Canada and Australia)
  15. Escaping the Long Shadow Cast by Agranulocytosis
  16. Respiratory aspiration during treatment with clozapine and other antipsychotics: a literature search and a pharmacovigilance study in VigiBase
  17. NURSING STUDENT’S VIEWS ON THE DUTY OF CARE: A CROSS-SECTIONAL STUDY IN TWO COUNTRIES
  18. Clozapine-induced myocarditis in children and adolescents: a pharmacovigilance study using VigiBase and a systematic literature review
  19. Respiratory aspiration during treatment with benzodiazepines, antiepileptic and antidepressant drugs in the pharmacovigilance database from VigiBase
  20. Telepsychiatry: The future is already present
  21. Psychometric Properties of the WHO-5 Well-Being Index among Nurses during the COVID-19 Pandemic: A Cross-Sectional Study in Three Countries
  22. Clozapine and the risk of haematological malignancies
  23. An international guideline with six personalised titration schedules for preventing myocarditis and pneumonia associated with clozapine
  24. Evaluating the Effect of a Telepsychiatry Educational Program on the Awareness, Knowledge, Attitude, and Skills of Telepsychiatry Among Spanish Psychiatrists during COVID-19 Pandemic
  25. An international clozapine titration guideline to increase its safety and move forward on the route started by German-speaking psychiatrists in the 1960s
  26. The duty to care and nurses' well-being during a pandemic
  27. Association between myocarditis and antipsychotics other than clozapine: a systematic literature review and a pharmacovigilance study using VigiBase
  28. Promoting safer clozapine dosing in the Americas
  29. An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels
  30. The Mediating Role of Resilience in the Relationship between Perceived Stress and Mental Health
  31. Miocarditis inducida por la clozapina: estudios animales pero no clínicos
  32. Clozapine-associated myocarditis in the World Health Organization’s pharmacovigilance database: Focus on reports from various countries
  33. Clinimetric Criteria for Patient-Reported Outcome Measures
  34. Exploring patterns in psychiatric outpatients’ preferences for involvement in decision-making: a latent class analysis approach
  35. Effect of necessity‐concern framework and polypharmacy on treatment adherence in psychiatric patients. Comparing an Argentinian with a Spanish sample
  36. An update on the complex relationship between clozapine and pneumonia
  37. Effects of a peer co-facilitated educational programme for parents of children with ADHD: a feasibility randomised controlled trial protocol
  38. Self-Report for Measuring and Predicting Medication Adherence: Experts’ Experience in Predicting Adherence in Stable Psychiatric Outpatients and in Pharmacokinetics
  39. Patient-reported well-being: psychometric properties of the world health organization well-being index in specialised community mental health settings
  40. Assessment of shared decision-making in community mental health care: Validation of the CollaboRATE
  41. Psychometric properties of the Five‐item World Health Organization Well‐being Index used in mental health services: Protocol for a systematic review
  42. The association of clozapine and haematological malignancies needs to be replicated by other studies and more importantly by analyses of subsamples from VigiBase
  43. A Rational Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and Clinical Pharmacopsychology
  44. Pneumonia may be more frequent and have more fatal outcomes with clozapine than with other second-generation antipsychotics
  45. The necessity‐concern framework in the assessment of treatment adherence of psychiatric patients and the role of polypharmacy in a Spanish sample
  46. Data From the World Health Organization’s Pharmacovigilance Database Supports the Prominent Role of Pneumonia in Mortality Associated With Clozapine Adverse Drug Reactions
  47. Development and validation of the Patient’s Health Belief Questionnaire on Psychiatric Treatment
  48. Effectiveness and cost-effectiveness of a multicomponent intervention to improve medication adherence in people with depressive disorders - MAPDep: a study protocol for a cluster randomized controlled trial
  49. Skepticism and pharmacophobia toward medication may negatively impact adherence to psychiatric medications: a comparison among outpatient samples recruited in Spain, Argentina, and Venezuela
  50. The Art of Pharmacotherapy
  51. Antipsychotics and driving ability
  52. Factors influencing adherence to psychopharmacological medications in psychiatric patients: a structural equation modeling approach
  53. Seguridad vial y toxicidad conductual por psicofármacos
  54. Reviving Research on Medication Attitudes for Improving Pharmacotherapy: Focusing on Adherence
  55. Validity of the Control Preferences Scale in patients with emotional disorders
  56. Treatment-related decisional conflict in patients with depressive and anxious disorders
  57. Preferencias por las decisiones compartidas en pacientes con depresión
  58. Coste-utilidad de asenapina frente a olanzapina para el tratamiento de los episodios maniacos de pacientes con trastorno bipolar tipo I
  59. Explaining pharmacophobia and pharmacophilia in psychiatric patients: relationship with treatment adherence
  60. To what extent is treatment adherence of psychiatric patients influenced by their participation in shared decision making?
  61. Preferences for participation in shared decision making of psychiatric outpatients with affective disorders
  62. Estrategias de manejo de los antidepresivos desde la perspectiva de los pacientes: luchando interna y externamente
  63. Editorial [Hot Topic: Compliance, Adherence and Concordance in Medicine Taking of Psychiatric Patients (Guest Editor: Carlos De las Cuevas)]
  64. Antidepressant Use in Early Pregnancy
  65. Lithium Use During Early, Late Pregnancy, and Breastfeeding
  66. Psychomotor performance and fitness to drive: The influence of psychiatric disease and its pharmacological treatment
  67. Versión española consensuada de la Severity of Dependence Scale (SDS)
  68. Attitudes toward psychiatric drug treatment: the experience of being treated
  69. Are psychotropics drugs used in pregnancy?
  70. Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy
  71. Telepsychiatry: Psychiatric consultation through videoconference patients' perception and satisfaction
  72. Telepsychiatry: Psychiatric consultation through videoconference clinical results
  73. Polypharmacy in psychiatric practice in the Canary Islands
  74. Evaluación cualitativa en teledermatología: resultados del proyecto piloto Telemedicina 2000
  75. Benzodiazepines: more "behavioural" addiction than dependence
  76. Burnout en los profesionales de la atención a las drogodependencias
  77. Telepsiquiatría: utopía o realidad asistencial
  78. Variations in antidepressant prescribing practice: clinical need or market influences?